Characteristics of patients with type 2 diabetes mellitus (CVD-RNDR)

Trial Identifier:	D1690R00048
Sponsor:	AstraZeneca
NCTID::	NCT03694470
Start Date:	April 2018
Primary Completion Date:	June 2018
Study Completion Date:	June 2018
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Moscow, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.